Maternal Fetal Health
Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Can Diet and Exercise Modulate Progression-Free Survival in Ovarian/Fallopian Tube/Primary Peritoneal Cancer Patients?
- Phase II Study of Pembrolizumab with SOC Treatment in Recurrent Ovarian Cancer
- Tesaro PR-30-5020-C: Phase II Study to Evaluate the Safety and Efficacy of Niraparib in Women with Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer